BioMarin Pharmaceutical
BMRN
#1885
Rank
A$15.59 B
Marketcap
A$81.19
Share price
-0.79%
Change (1 day)
-21.27%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): A$1.06 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.09 Billion. In 2024 the company made an earning of A$0.77 Billion, an increase over its 2023 earnings that were of A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.06 B37.17%
2024 A$0.77 B187.31%
2023 A$0.27 B26.07%
2022 A$0.21 B-298.51%
2021 -A$0.11 Billion78.04%
2020 -A$60.78 Million-55.36%
2019 -A$0.14 Billion-33.56%
2018 -A$0.21 Billion297.78%
2017 -A$51.52 Million-95.68%
2016 -A$1.2 Billion437.12%
2015 -A$0.23 Billion23.91%
2014 -A$0.18 Billion-29.25%
2013 -A$0.26 Billion49.23%
2012 -A$0.17 Billion171.11%
2011 -A$62.65 Million103.01%
2010 -A$30.86 Million-3903.54%
2009 A$0.81 M-98.31%
2008 A$47.99 M-189.7%
2007 -A$53.51 Million51.02%
2006 -A$35.44 Million-61.58%
2005 -A$92.22 Million-56.59%
2004 -A$0.22 Billion95.13%
2003 -A$0.11 Billion12.09%
2002 -A$97.11 Million73.19%
2001 -A$56.08 Million18.32%
2000 -A$47.39 Million19.65%
1999 -A$39.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$13.06 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.75 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$39.41 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$7.15 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.41 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA